AT359197B - METHOD FOR PRODUCING PHARMACEUTICAL PREPARATIONS - Google Patents

METHOD FOR PRODUCING PHARMACEUTICAL PREPARATIONS

Info

Publication number
AT359197B
AT359197B AT848077A AT848077A AT359197B AT 359197 B AT359197 B AT 359197B AT 848077 A AT848077 A AT 848077A AT 848077 A AT848077 A AT 848077A AT 359197 B AT359197 B AT 359197B
Authority
AT
Austria
Prior art keywords
pharmaceutical preparations
producing pharmaceutical
producing
preparations
pharmaceutical
Prior art date
Application number
AT848077A
Other languages
German (de)
Other versions
ATA848077A (en
Original Assignee
Pennwalt Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pennwalt Corp filed Critical Pennwalt Corp
Publication of ATA848077A publication Critical patent/ATA848077A/en
Application granted granted Critical
Publication of AT359197B publication Critical patent/AT359197B/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/58—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. poly[meth]acrylate, polyacrylamide, polystyrene, polyvinylpyrrolidone, polyvinylalcohol or polystyrene sulfonic acid resin
    • A61K47/585—Ion exchange resins, e.g. polystyrene sulfonic acid resin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/14—Antitussive agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
AT848077A 1976-11-26 1977-11-25 METHOD FOR PRODUCING PHARMACEUTICAL PREPARATIONS AT359197B (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US74532576A 1976-11-26 1976-11-26
US80010577A 1977-05-24 1977-05-24

Publications (2)

Publication Number Publication Date
ATA848077A ATA848077A (en) 1980-03-15
AT359197B true AT359197B (en) 1980-10-27

Family

ID=27114439

Family Applications (1)

Application Number Title Priority Date Filing Date
AT848077A AT359197B (en) 1976-11-26 1977-11-25 METHOD FOR PRODUCING PHARMACEUTICAL PREPARATIONS

Country Status (21)

Country Link
JP (1) JPS609697B2 (en)
AR (1) AR218047A1 (en)
AT (1) AT359197B (en)
AU (1) AU511080B2 (en)
BE (1) BE861141A (en)
CA (1) CA1086226A (en)
CH (1) CH639560A5 (en)
DE (1) DE2752728C2 (en)
DK (1) DK150534C (en)
FI (1) FI65910C (en)
FR (1) FR2373288A1 (en)
GB (1) GB1544761A (en)
GR (1) GR61724B (en)
IE (1) IE45998B1 (en)
IL (1) IL53462A (en)
LU (1) LU78584A1 (en)
NL (1) NL182283C (en)
NO (1) NO147626C (en)
NZ (1) NZ185772A (en)
PT (1) PT67323B (en)
SE (1) SE426781B (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0435684A1 (en) * 1989-12-28 1991-07-03 R.P. Scherer Corporation Freeze-dried dosage forms and methods for preparing the same

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2929456A1 (en) 1979-07-20 1981-02-05 Lentia Gmbh COMPOSITION WITH EXTENDED BRONCHOLYTIC AND TOCOLYTIC EFFECTIVENESS, A METHOD FOR THE PRODUCTION THEREOF AND BRONCHOLYTIC AND TOKOLYTICALLY ACTIVE AGENT
CA1236023A (en) * 1984-07-18 1988-05-03 Yegnaswami Raghunathan Controlled release pharmaceutical preparations
US4692462A (en) * 1985-03-18 1987-09-08 Menley & James Laboratories, Ltd. Compositions and method of controlling transdermal penetration of topical and systemic agents
US5612059A (en) * 1988-08-30 1997-03-18 Pfizer Inc. Use of asymmetric membranes in delivery devices
CA2087435C (en) * 1990-08-07 1998-05-05 Scott Max Herbig Use of interfacially-polymerized membranes in delivery devices
US5436011A (en) * 1993-04-16 1995-07-25 Bristol-Myers Squibb Company Solid pharmaceutical dosage form and a method for reducing abrasion
US20130230587A1 (en) * 2010-11-10 2013-09-05 Rubicon Research Private Limited Sustained release compositions
FR3059903B1 (en) * 2016-12-08 2019-03-22 Salsarulo Pharma ORAL MEDICINE COMPRISING AN OSMOTIC LAXATIVE INCORPORATED IN A MATRIX BASED ON VEGETABLE FATS
JP2020536892A (en) 2017-10-09 2020-12-17 ローズ ファーマシューティカルズ エル．ピー． Pharmaceutical resinate composition, how to make it, and its use

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE550150A (en) * 1955-08-08
GB843118A (en) * 1957-02-13 1960-08-04 Ici Ltd Pharmaceutical compositions containing piperidine derivatives
US3158538A (en) * 1961-02-23 1964-11-24 White Lab Inc Antidiarrheal compositions and method of using
GB982150A (en) * 1961-09-29 1965-02-03 Glaxo Group Ltd Therapeutic resin complexes
US3594470A (en) * 1968-02-19 1971-07-20 Abbott Lab Chewable tablets including coated particles of pseudoephedrine-weak cation exchange resin
GB1218102A (en) * 1968-03-15 1971-01-06 Philips Nv Improvements in medicaments comprising drug/ion-exchange resin compounds
CA927282A (en) * 1968-09-03 1973-05-29 S. Banker Gilbert Entrapment compositions and processes
CA935092A (en) * 1968-09-03 1973-10-09 S. Banker Gilbert Molecular drug entrapment process and compositions
DE2343218C2 (en) * 1973-08-28 1986-08-07 Hoechst Ag, 6230 Frankfurt Pellets containing furosemide

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0435684A1 (en) * 1989-12-28 1991-07-03 R.P. Scherer Corporation Freeze-dried dosage forms and methods for preparing the same

Also Published As

Publication number Publication date
JPS609697B2 (en) 1985-03-12
PT67323A (en) 1977-12-01
NO147626B (en) 1983-02-07
FI773568A (en) 1978-05-27
FR2373288B1 (en) 1980-06-13
CA1086226A (en) 1980-09-23
AU3098677A (en) 1979-05-31
DK150534C (en) 1987-10-12
SE7713370L (en) 1978-05-27
IE45998L (en) 1978-05-26
IL53462A (en) 1980-12-31
LU78584A1 (en) 1978-04-20
SE426781B (en) 1983-02-14
NZ185772A (en) 1978-12-18
NL7712996A (en) 1978-05-30
AR218047A1 (en) 1980-05-15
NL182283B (en) 1987-09-16
GR61724B (en) 1978-12-29
AU511080B2 (en) 1980-07-24
GB1544761A (en) 1979-04-25
DK523277A (en) 1978-05-27
NO774051L (en) 1978-05-29
ATA848077A (en) 1980-03-15
FI65910B (en) 1984-04-30
PT67323B (en) 1979-04-24
NO147626C (en) 1983-05-25
FI65910C (en) 1984-08-10
CH639560A5 (en) 1983-11-30
IE45998B1 (en) 1983-01-26
JPS5369822A (en) 1978-06-21
FR2373288A1 (en) 1978-07-07
DE2752728C2 (en) 1985-08-01
DK150534B (en) 1987-03-23
DE2752728A1 (en) 1978-06-01
NL182283C (en) 1988-02-16
IL53462A0 (en) 1978-01-31
BE861141A (en) 1978-03-16

Similar Documents

Publication Publication Date Title
LU77562A1 (en) METHOD FOR PRODUCING NEW PHARMACEUTICAL PREPARATIONS
AT360654B (en) METHOD FOR PRODUCING PHARMACEUTICAL COMPOSITIONS
AT371709B (en) METHOD FOR PRODUCING PHARMACEUTICAL PREPARATIONS IN DOSING UNIT FORM
AT364451B (en) METHOD FOR PRODUCING LOCALANETHETICALLY EFFECTIVE COMBINATION PREPARATIONS
AT383271B (en) METHOD FOR PRODUCING CEREBRAL-ACTIVE MEDICINAL PRODUCTS
AT363196B (en) METHOD FOR PRODUCING ANDROSTAN-17-ON DERIVATIVES
AT371708B (en) METHOD FOR PRODUCING PHARMACEUTICAL UNIT DOSAGE FORMS
AT381025B (en) METHOD FOR PRODUCING TOPICAL PHARMACEUTICAL PREPARATIONS
AT366576B (en) METHOD FOR PRODUCING PHARMACEUTICAL PREPARATIONS
AT367295B (en) METHOD FOR PRODUCING PHARMACEUTICAL COMPOSITIONS
AT354655B (en) METHOD FOR PRODUCING NEW PEPTIDE DERIVATIVES
AT359197B (en) METHOD FOR PRODUCING PHARMACEUTICAL PREPARATIONS
AT363174B (en) METHOD FOR PRODUCING PHARMACEUTICAL PREPARATIONS
AT353993B (en) METHOD FOR PRODUCING NEW PEPTIDE DERIVATIVES
ATA803679A (en) METHOD FOR PRODUCING GALENIC PREPARATIONS
AT365452B (en) METHOD FOR PRODUCING PHARMACEUTICAL PREPARATIONS
AT366574B (en) METHOD FOR PRODUCING PHARMACEUTICAL PREPARATIONS FOR ORAL ADMINISTRATION
AT343125B (en) METHOD FOR PREPARING 3-PHENYLPYRIDAZONE- (6)
AT378915B (en) METHOD FOR PRODUCING ANTI-HYPERTENSIVE PHARMACEUTICAL PREPARATIONS
ATA136279A (en) METHOD FOR PRODUCING PHARMACEUTICAL PREPARATIONS
AT357261B (en) METHOD FOR PRODUCING CYTOSTATICALLY ACTIVE DRUG PREPARATIONS
AT355740B (en) METHOD FOR PRODUCING NEW PEPTIDE DERIVATIVES
DD137057A5 (en) PROCESS FOR PREPARING PHARMACEUTICAL PREPARATIONS FOR INHIBITING THE LIPOGENESIS
ATA966976A (en) METHOD FOR PRODUCING 2-AMINOINE DERIVATIVES
ATA236577A (en) METHOD FOR PRODUCING INJECTION PREPARATIONS

Legal Events

Date Code Title Description
ELJ Ceased due to non-payment of the annual fee
EWE Authorization for restitution
ELJ Ceased due to non-payment of the annual fee